Receptor Life Sciences
Seattle
About Receptor Life Sciences
Receptor Life Sciences provides nervous system disorders and drug-delivery technologies. They also provide oral cannabinoid products and commercialization of therapies that fill unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Website: receptorlife.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/receptor-life-sciences-24761 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.